New clues to the link between ALS and type 2 diabetes

Amyotrophic Lateral Sclerosis
An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent with the diagnosis of ALS. Credit: Frank Gaillard/Wikipedia

Patients with ALS (amyotrophic lateral sclerosis) often suffer from type 2 diabetes. This phenomenon has long remained mechanistically enigmatic. Now, researchers at Karolinska Institutet in Sweden have identified a molecular mechanism linking these two diseases. The study is published in the scientific journal PNAS.

The researchers found that immunoglobulin G (IgG) antibodies in the blood of ALS patients target the in the cell membrane of the insulin-secreting beta in the pancreas. "This leads to an unphysiological calcium (Ca2+) influx and consequent beta cell death," says Dr. Yue Shi, first author of the study and Postdoctoral researcher at the Department of Molecular Medicine and Surgery, Karolinska Institutet.

Altered humoral immunity, i.e. the presence of autoantibodies targeting the body's own cells, is a known phenomenon in type 1 diabetes. The new study highlights the presence of autoantibodies as a pathogenic mechanism in a subgroup of patients with type 2 diabetes.

"We now demonstrate that IgG from ALS patients with type 2 diabetes behave like cytotoxic autoantibodies, suggesting that altered humoral immunity can serve as a critical pathogenic mechanism in the development of diabetes," says Dr. Shao-Nian Yang, associate professor at the Department of Molecular Medicine and Surgery, Karolinska Institutet, and senior author of the study. "This may lay the foundation for a new immunotherapy strategy for patients suffering from both ALS and diabetes."

The researchers believe that the presence of autoantibodies may be a generalized phenomenon for other neurodegenerative diseases as well. Similar to ALS patients, a proportion of patients with disorders like Alzheimer's disease, Parkinson's disease and multiple sclerosis also suffer from type 2 diabetes.

"Interestingly, pancreatic and neurons are equipped with similar types of calcium channels and share a series of physiological and pathological mechanisms for their function/dysfunction and survival/death, such as Ca2+-dependent exocytosis and Ca2+-triggered cell death," says Professor Per-Olof Berggren, Director of the Rolf Luft Research Center, Karolinska Institutet, and senior author of the study. "The extent to which the pathogenic mechanism that we discovered in patients with both ALS and type 2 diabetes may be generalized to other neurodegenerative diseases associated with will be the focus for future studies."


Explore further

New potential target for treatment of diabetes

More information: Yue Shi el al., "IgGs from patients with amyotrophic lateral sclerosis and diabetes target CaVα2δ1 subunits impairing islet cell function and survival," PNAS (2019). www.pnas.org/cgi/doi/10.1073/pnas.1911956116
Citation: New clues to the link between ALS and type 2 diabetes (2019, December 9) retrieved 24 January 2020 from https://medicalxpress.com/news/2019-12-clues-link-als-diabetes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
66 shares

Feedback to editors

User comments